Free Trial

Nihon Kohden (OTCMKTS:NHNKY) Stock Price Down 4.5% - Here's What Happened

Nihon Kohden logo with Medical background

Key Points

  • Nihon Kohden's stock price fell 4.5% to $11.68, with trading volume significantly down to 263 shares, drastically less than its usual average of 5,581 shares.
  • The company reported $0.01 earnings per share for the last quarter, with a revenue of $346.24 million and a return on equity of 6.74%.
  • Nihon Kohden is engaged in developing and manufacturing medical electronic equipment, offering products such as patient monitoring systems and treatment equipment like defibrillators and pacemakers.
  • MarketBeat previews top five stocks to own in November.

Nihon Kohden Corporation (OTCMKTS:NHNKY - Get Free Report)'s stock price dropped 4.5% on Wednesday . The stock traded as low as $11.68 and last traded at $11.68. Approximately 263 shares changed hands during trading, a decline of 95% from the average daily volume of 5,581 shares. The stock had previously closed at $12.23.

Nihon Kohden Trading Up 2.2%

The company has a market cap of $2.14 billion, a price-to-earnings ratio of 23.15 and a beta of 0.41. The company has a fifty day moving average price of $11.64 and a two-hundred day moving average price of $11.97.

Nihon Kohden (OTCMKTS:NHNKY - Get Free Report) last announced its quarterly earnings data on Wednesday, August 6th. The company reported $0.01 earnings per share for the quarter. Nihon Kohden had a return on equity of 6.74% and a net margin of 5.77%.The company had revenue of $346.24 million for the quarter.

Nihon Kohden Company Profile

(Get Free Report)

Nihon Kohden Corporation engages in development, manufacturing, sale, maintenance, and consultation of medical electronic equipment, and related systems and products in Japan, Americas, Europe, rest of Asia, and internationally. It offers physiological measuring equipment comprising electrocardiographs, electroencephalographs, and polygraphs for Cath-labs; patient monitoring systems, such as beside and central monitors; and treatment equipment including defibrillators, automated external defibrillators, ventilators, and pacemakers.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Nihon Kohden Right Now?

Before you consider Nihon Kohden, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nihon Kohden wasn't on the list.

While Nihon Kohden currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.